Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-11
DOI
10.1007/s40262-021-01070-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin
- (2021) David Busse et al. PHARMACEUTICAL RESEARCH
- Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
- (2021) Uwe Liebchen et al. Antibiotics-Basel
- Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy
- (2020) L. Ehmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study
- (2020) Philipp Simon et al. Journal of Clinical Medicine
- Quantification of microdialysis related variability in Humans: clinicAL trial design recommendations
- (2020) D Busse et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics
- (2020) Selina Schießer et al. THERAPEUTIC DRUG MONITORING
- Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial
- (2020) Philipp Simon et al. Antibiotics-Basel
- Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis
- (2019) Lisa Ehmann et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- De‐indexed eGFR: A simple step towards improving accuracy of drug dosing of renally excreted medications in moderate to severe obesity
- (2019) Caitlyn Vlasschaert et al. NEPHROLOGY
- Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment
- (2018) Pelle Hanberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment options for carbapenem
- (2018) Moritz Fritzenwanker et al. Deutsches Arzteblatt International
- Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
- (2018) Iris K Minichmayr et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug combinations and impact of experimental conditions on relative recovery in in vitro microdialysis investigations
- (2018) Daniela Burau et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
- (2017) Sahand Imani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comprehensive Guidance for Antibiotic Dosing in Obese Adults
- (2017) Lina Meng et al. PHARMACOTHERAPY
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
- (2016) Abdulaziz S. Alobaid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients
- (2016) Eun Kyoung Chung et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study
- (2016) Vidar Tor Nyborg Stefansson et al. BMC Nephrology
- Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery
- (2015) Mathias Wittau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
- (2015) Marta Ulldemolins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
- (2014) G. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study
- (2014) Frédéric Frippiat et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- A Pharmacokinetic Standard for Babies and Adults
- (2013) Nick Holford et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The effect of obesity on antibiotic treatment failure: a historical cohort study
- (2013) Cristina Longo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections
- (2013) Lutz Binder et al. THERAPEUTIC DRUG MONITORING
- Case-Control Study of Drug Monitoring of -Lactams in Obese Critically Ill Patients
- (2012) M. Hites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Various Body Weights and Serum Creatinine Concentrations on the Bias and Accuracy of the Cockcroft-Gault Equation
- (2012) Mary A. Winter et al. PHARMACOTHERAPY
- The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study
- (2011) Yehuda Carmeli et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09
- (2011) Todd A. Davies et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic dosing in critical illness
- (2011) C. McKenzie JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
- (2008) Peggy S. McKinnon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extensions to the Visual Predictive Check to facilitate model performance evaluation
- (2008) Teun M. Post et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now